1. Home
  2. OCFC vs OGN Comparison

OCFC vs OGN Comparison

Compare OCFC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OceanFirst Financial Corp.

OCFC

OceanFirst Financial Corp.

HOLD

Current Price

$18.90

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.76

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OCFC
OGN
Founded
1902
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
OCFC
OGN
Price
$18.90
$13.76
Analyst Decision
Buy
Hold
Analyst Count
3
5
Target Price
$21.67
$11.40
AVG Volume (30 Days)
967.2K
2.8M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
4.24%
0.60%
EPS Growth
N/A
N/A
EPS
0.27
0.95
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$47.51
$0.45
Revenue Next Year
$21.97
$1.67
P/E Ratio
$69.93
$14.48
Revenue Growth
N/A
N/A
52 Week Low
$17.05
$5.69
52 Week High
$20.61
$13.77

Technical Indicators

Market Signals
Indicator
OCFC
OGN
Relative Strength Index (RSI) 43.21 72.77
Support Level $17.31 $13.46
Resistance Level $19.35 N/A
Average True Range (ATR) 0.31 0.03
MACD -0.06 -0.00
Stochastic Oscillator 20.18 91.67

Price Performance

Historical Comparison
OCFC
OGN

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: